![](/img/cover-not-exists.png)
IL-2- or IL-15-activated NK cells enhance Cetuximab-mediated activity against triple-negative breast cancer in xenografts and in breast cancer patients
María P. Roberti, Yamila S. Rocca, Mora Amat, María B. Pampena, José Loza, Federico Coló, Verónica Fabiano, Carlos M. Loza, Juan M. Arriaga, Michele Bianchini, María M. Barrio, Alicia I. Bravo, Enzo DVolume:
136
Language:
english
DOI:
10.1007/s10549-012-2287-y
Date:
December, 2012
File:
PDF, 756 KB
english, 2012